Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern

Biomedicine and Pharmacotherapy

Volumn 65, Issue 1, 2011, Pages 40-45

  Işeri, Özlem Darcansoy ^a,b   Kars, Meltem Demirel ^a   Arpaci, Fikret ^c   Atalay, Can ^d   Pak, Işin ^d   Gündüz, Ufuk ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d ANKARA ONCOLOGY HOSPITAL   (Turkey)

Author keywords

Breast cancer; EMT; Multidrug resistance

Indexed keywords

COMPLEMENTARY DNA; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR ALPHA; NERVE CELL ADHESION MOLECULE; OCCLUDIN; PACLITAXEL; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UVOMORULIN; VIMENTIN;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 79951681780     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.10.004     Document Type: Article

References (29)

1. Sanfilippo O., Ronchi E., De Marco C., Di Fronzo G., Silvestrini R. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer 1991, 27:155-158.
2. Dalton W.S. Mechanisms of drug resistance in hematologic malignancies. Semin Hematol 1997, 34:3-8.
3. Young A.M., Allen C.E., Audus K.L. Efflux transporters of the human placenta. Adv Drug Deliver Rev 2003, 55:125-132.
4. Sarrió D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008, 68(4):989-997.
5. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 2003, 22(10):2318-2323.
6. Thompson E.W., Newgreen D.F., Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?. Cancer Res 2005, 65(14):5991-5995.
7. Voulgari A., Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009, 1796(2):75-90.
8. Kars M.D., Işeri O.D., Gündüz U., Ural A.U., Arpaci F., Molnar J. Development of rational in-vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds. Anticancer Res 2006, 26:4559-4568.
9. Işeri ÖD, Kars M.D., Eroĝlu S., Gündüz U. Drug resistant MCF-7 cell lines also developed cross-resistance to structurally unrelated anticancer agents. Int J Hem Oncol 2009, 19(1):1-8.
10. Işeri O.D., Kars M.D., Arpaci F., Gündüz U. Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins. Cancer Chemother Pharmacol 2010, 65(3):447-455.
11. Kajita M., McClinic K.N., Wade P.A. Aberrant expression of the transcription factors snail and Slug alters the response to genotoxic stress. Mol Cell Biol 2004, 24(17):7559-7566.
12. Ye Y., Xiao Y., Wang W., Yearsley K., Gao J.X., Barsky S.H. ERalpha suppresses Slug expression directly by transcriptional repression. Biochem J 2008, 416(2):179-187.
13. Hajra K.M., Chen D.Y., Fearon E.R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002, 62(6):1613-1618.
14. Jethwa P., Naqvi M., Hardy R.G., Hotchin N.A., Roberts S., Spychal R., et al. Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol 2008, 14(7):1044-1052.
15. Hazan R.B., Qiao R., Keren R., Badano I., Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004, 1014:155-163.
16. Suyama K., Shapiro I., Guttman M., Hazan R.B. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002, 2(4):301-314.
17. Xian W., Schwertfeger K.L., Vargo-Gogola T., Rosen J.M. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J Cell Biol 2005, 171(4):663-673.
18. Choi J., Park S.Y., Joo C.K. Transforming growth factor-beta1 represses E-cadherin production via Slug expression in lens epithelial cells. Invest Ophthalmol Vis Sci 2007, 48(6):2708-2718.
19. Zavadil J., Böttinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24(37):5764-5774.
20. Wilkins-Port C.E., Higgins P.J. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Cells Tissues Organs 2007, 185(1-3):116-122.
21. Dhawan P., Singh A.B., Deane N.G., No Y., Shiou S.R., Schmidt C., et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005, 115(7):1765-1776.
22. Leotlela P.D., Wade M.S., Duray P.H., Rhode M.J., Brown H.F., Rosenthal D.T., et al. Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 2007, 26(26):3846-3856.
23. Lioni M., Brafford P., Andl C., Rustgi A., El-Deiry W., Herlyn M., et al. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 2007, 170(2):709-721.
24. Carrozzino F., Soulié P., Huber D., Mensi N., Orci L., Cano A., et al. Inducible expression of snail selectively increases paracellular ion permeability and differentially modulates tight junction proteins. Am J Physiol Cell Physiol 2005, 289(4):C1002-1014.
25. Ueda J., Semba S., Chiba H., Sawada N., Seo Y., Kasuga M., et al. Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology 2007, 74(1):32-41.
26. Hewitt K.J., Agarwal R., Morin P.J. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006, 6:186.
27. Kominsky S.L. Claudins: emerging targets for cancer therapy. Expert Rev Mol Med 2006, 8(18):1-11.
28. Jechlinger M., Grunert S., Tamir I.H., Janda E., Lüdemann S., Waerner T., et al. Expression profiling of epithelial plasticity in tumor progression. Oncogene 2003, 22(46):7155-7169.
29. Bronstein J.M., Chen K., Tiwari-Woodruff S., Kornblum H.I. Developmental expression of OSP/claudin-11. J Neurosci Res 2000, 60(3):284-290.